Deka Bank Deutsche Girozentrale Mersana Therapeutics, Inc. Transaction History

Deka Bank Deutsche Girozentrale

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$5.48 - $9.86 $115,080 - $207,060	-21,000 Closed	0 $0
Q4 2020 Mar 12, 2021	BUY	$16.84 - $27.59 $353,640 - $579,390	21,000 New	21,000 $568,000
Q2 2018 Aug 14, 2018	SELL	$14.2 - $22.68 $278,320 - $444,528	-19,600 Closed	0 $0
Q1 2018 May 03, 2018	SELL	$13.56 - $18.48 $141,024 - $192,192	-10,400 Reduced 34.67%	19,600 $312,000
Q3 2017 Nov 06, 2017	BUY	$14.8 - $18.06 $444,000 - $541,800	30,000	30,000 $461,000

121

116M

233K

457K

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $194M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.